0001209191-23-002778.txt : 20230110 0001209191-23-002778.hdr.sgml : 20230110 20230110161825 ACCESSION NUMBER: 0001209191-23-002778 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230106 FILED AS OF DATE: 20230110 DATE AS OF CHANGE: 20230110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Allison David D. CENTRAL INDEX KEY: 0001853903 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41201 FILM NUMBER: 23521362 MAIL ADDRESS: STREET 1: C/O IMPEL NEUROPHARMA, INC. STREET 2: 201 ELLIOTT AVE. W, ST. 260 CITY: SEATTLE STATE: WA ZIP: 98119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CinCor Pharma, Inc. CENTRAL INDEX KEY: 0001868734 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 230 THIRD AVE., 6TH FLOOR CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 8445311834 MAIL ADDRESS: STREET 1: 230 THIRD AVE., 6TH FLOOR CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-06 0 0001868734 CinCor Pharma, Inc. CINC 0001853903 Allison David D. C/O CINCOR PHARMA, INC. 230 THIRD AVENUE, 6TH FLOOR WALTHAM MA 02451 1 0 0 0 Stock Option (Right to Buy) 11.78 2023-01-06 4 A 0 1499 8.34 A 2023-01-06 2033-01-05 Common Stock 1499 1499 D This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $12,500. /s/ Cathy Rude, Attorney-in-Fact 2023-01-10